5-Phosphoribosyl pyrophosphate

Figure20-2. The pentose phosphate pathway. ( ,— PRPP, 5-phosphoribosyl 1-pyrophosphate.)...

Seasonal variations in the metabolic fate of adenine nucleotides prelabelled with [8—1-4C] adenine were examined in leaf disks prepared at 1-month intervals, over the course of 1 year, from the shoots of tea plants (Camellia sinensis L. cv. Yabukita) which were growing under natural field conditions by Fujimori et al.33 Incorporation of radioactivity into nucleic acids and catabolites of purine nucleotides was found throughout the experimental period, but incorporation into theobromine and caffeine was found only in the young leaves harvested from April to June. Methy-lation of xanthosine, 7-methylxanthine, and theobromine was catalyzed by gel-filtered leaf extracts from young shoots (April to June), but the reactions could not be detected in extracts from leaves in which no synthesis of caffeine was observed in vivo. By contrast, the activity of 5-phosphoribosyl-1-pyrophosphate synthetase was still found in leaves harvested in July and August. 

A different, simpler , pathway is involved in the synthesis of pyrimidine nucleotides. A pyrimidine base (orotate), is synthesised first. Then the ribose is added from 5-phosphoribosyl 1-pyrophosphate. The two precursors for the formation of orotate are carbamoylphosphate and aspartate, which form carbamoyl aspartate, catalysed by aspartate carbamoyltransferase. 

The purine and pyrimidine bases can be converted to then-respective nncleotides by reaction with 5-phosphoribosyl 1-pyrophosphate. Since these bases are not very soluble, they are not transported in the blood, so that the reactions are only of qnantitative significance in the intestine, where the bases are produced by degradation of nucleotides. In contrast, in some cells, nucleosides are converted back to nucleotides by the activity of kinase enzymes. In particular, adenosine is converted to AMP, by the action of adenosine kinase, and uridine is converted to UMP by a uridine kinase... 

Figure 10-1. Overview of purine synthesis. Details of the first two reactions and sources of the atoms of the purine ring in inosine 5 -monophosphate (IMP) are shown. PRPP, 5 -phosphoribosyl-1-pyrophosphate Gin, glutamine Gly, glycine Asp, aspartate THF, tetrahydrofolate.

Figure 10-2. Regulation of purine synthesis by the nucleotides and the intermediate, 5 -phosphoribosyl-1 -pyrophosphate (PRPP). Both feedback and feed-forward mechanisms are utilized in this intricate scheme. IMP, inosine monophosphate.

Two steps aspartate PRPP, 5 -phosphoribosyl-1 -pyrophosphate UMP, uridine... 

Attack at the /3 phosphate of ATP displaces AMP and transfers a pyrophosphoiyl (not pyrophosphate) group to the attacking nucleophile (Pig. 13-10b). For example, the formation of 5 -phosphoribosyl-1-pyrophosphate (p. XXX), a key intermediate in nucleotide synthesis, results from attack of an —OH of the ribose on the /3 phosphate. 

Synthesis of 5-phosphoribosyl-1-pyrophosphate (PRPP), showing the activator and inhibitors of the reaction. 

Parry, R.J. et al. Synthesis of 1 a-Pyrophosphoryl-2 a.3 a-dihydroxy-4/3-cyclopentanemethanol-5-phosphate, a Carbocyclic Analog of 5-Phosphoribosyl-1-pyrophosphate (PRPP). 2.1 1993 [168]... 

The atoms of the pyrimidine ring are derived from carbamoyl phosphate and aspartate, as shown in Fig. 15-14. The de novo biosynthesis of pyrimidine nucleotides is shown in Fig. 15-15. The first completely formed pyrimidine ring is that of dihydroorotate. Only after oxidation to orotate is the ribose attached to produce orotidylate. The compound 5-phosphoribosyl 1-pyrophosphate (P-Rib-PP) provides the ribose phosphate. L-Glutamine is used as a substrate donating nitrogen atoms at reactions 1 and 9, catalyzed by carbamoyl phosphate synthetase II and CTP synthetase, respectively a second... 

Fig. 15-16 The de novo purine biosynthetic pathway. Rib-5-P, ribose 5-phosphate P-Rib-PP, 5-phosphoribosyl 1-pyrophosphate PRA, 5-phosphoribosylamine IO-CHO-FH4, /Vl0-formyl tetrahydrofolate GAR, glycineamide ribotide FGAR. /V-formylglycineamide ribotide FGAM, /V-formylglycineamidine ribotide AIR, 5-aminoimidazole ribotide CAIR, 4-carboxy-5-aminoimidazole ribotide SAICAR, iV-succino-5-aminoimidazole-4-carboxamide ribotide AICAR, 5-aminoimidazole-4-carboxamide ribotide FAICAR, 5-formamidoimidazole-4-carboxamide ribotide sAMP, /V-succino-AMP. Enzymes (1) amido phosphoribosyltransferase (2) GAR synthetase (3) GAR transformylase (4) FGAM synthetase (5) AIR synthetase (6) AIR carboxylase (7) SAICAR synthetase (8) adenylosuecinase (9) AICAR transformylase (10) IMP cyclohydrolase (11) sAMP synthetase (12) adenylosuecinasc (13) IMP dehydrogenase (14) GMP synthetase.

Figure 25.1. Salvage and de Novo Pathways. In a salvage pathway, a base is reattached to a ribose, activated in the form of 5-phosphoribosyl-1-pyrophosphate (PRPP). In de novo synthesis, the base itself is synthesized from simpler starting materials, including amino acids. ATP hydrolysis is required for de novo synthesis.

The pyrimidine ring is assembled first and then linked to ribosc phosphate to form a pyrimidine nucleotide. 5-Phosphoribosyl-1-pyrophosphate is the donor of the ribose phosphate moiety. The synthesis of the pyrimidine ring starts with the formation of carbamoylas-partate from carbamoyl phosphate and aspartate, a reaction catalyzed by aspartate transcarbamoylase. Dehydration, cyclization, and oxidation yield orotate, which reacts with PRPP to give orotidylate. Decarboxylation of this pyrimidine nucleotide yields UMP. CTP is then formed by the amination of UTP,... 

The crystal structure of hypoxanthine phosphoribosyltransferase has been solved in a ternary complex of the enzyme with the substrate 5-phosphoribosyl 1-pyrophosphate (PRPP) and an analogue of hypoxanthine with a carbon atom in place of As with PNP and OPRTase, these structures showed many contacts with... 

FIGURE 51—4 Sites of action of methotrexate and its pofyglutamates. AICAR, aminoimidazole carboxamide TMR thymidine monophosphate dUMP, deoxyuridine monophosphate FH Glu, dihydrofolate polyglutamate FH Glu, tetrahydrofolate polyglutamate GAR, glycinamide ribonucleotide IMP, inosine monophosphate PRPP, 5-phosphoribosyl-1 -pyrophosphate. 

FIGURE 51-5 Activation pathways for 5 fluorouracil (5-FU) and 5-floxuridine (FUR). FUDP, floxuridine diphosphate FUMP, floxuridine monophosphate FUTP, floxuridine triphosphate FUdR, fluorodeoxyuridine FdUDP fluorodeoxyuridine diphosphate FdUMP fluorodeoxyuridine monophosphate FdUTP fluorodeoxyuridine triphosphate PRPP 5-phosphoribosyl-1 -pyrophosphate. 

---